Dashboard
Manage Tickers

DVAXDYNAVAX TECHNOLOGIES CORP

Nasdaq dynavax.com


$ 11.44 $ 0.18 (1.6 %)    

Friday, 21-Jun-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 478.55 $ -0.62 (-0.13 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.75 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 11.43
$ 11.36
$ 0.00 x 0
$ 0.00 x 0
$ 11.25 - $ 11.50
$ 10.48 - $ 15.15
12,118,008
na
1.49B
$ 1.07
$ 161.37
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-11-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 03-08-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 08-07-2017 06-30-2017 10-Q
29 05-08-2017 03-31-2017 10-Q
30 03-13-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 03-08-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-05-2015 12-31-2014 10-K
39 11-05-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-dynavax-technologies-maintains-29-price-target
HC Wainwright & Co. Reiterates Buy on Dyna...
05/14/2024 15:19:48

HC Wainwright & Co. analyst Edward White reiterates Dynavax Technologies (NASDAQ:DVAX) with a Buy and maintains $29 pric...

fda-declines-to-approve-expanded-use-of-dynavaxs-hepatitis-b-vaccine-in-hemodialysis-patients
FDA Declines To Approve Expanded Use of Dy...
05/14/2024 14:10:02

Latest regulatory update from Dynavax on HEPLISAV-B vaccine regimen for adults on hemodialysis, with FDA's Complete Respons...

fda-issued-complete-response-letter-to-dynavax-saying-sbla-for-four-dose-heplisav-b-regimen-did-not-provide-sufficient-data-to-support-full-evaluation-of-effectiveness-or-safety
FDA Issued Complete Response Letter To Dyn...
05/14/2024 12:35:48

hc-wainwright--co-reiterates-buy-on-dynavax-technologies-maintains-29-price-target
HC Wainwright & Co. Reiterates Buy on Dyna...
05/09/2024 10:50:33

HC Wainwright & Co. analyst Edward White reiterates Dynavax Technologies (NASDAQ:DVAX) with a Buy and maintains $29 pric...

dynavax-reaffirms-full-year-2024-financial-guidance-expects-cash--equivalents-to-be-higher-yy-at-december-31-2024
Dynavax Reaffirms Full Year 2024 Financial...
05/08/2024 20:56:05

HEPLISAV-B net product revenue between approximately $265 - $280 million, including approximately $3 million in ex-U.S. sales...

dynavax-technologies-q1-2024-gaap-eps-007-misses-003-estimate-sales-50790m-miss-54975m-estimate
Dynavax Technologies Q1 2024 GAAP EPS $(0....
05/08/2024 20:02:29

Dynavax Technologies (NASDAQ:DVAX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate o...

dynavax-technologies-sees-fy24-net-product-revenue-265m-280m-vs-290628m-est
Dynavax Technologies Sees FY24 Net Product...
02/22/2024 21:37:55

dynavax-technologies-q4-earnings-insights
Dynavax Technologies: Q4 Earnings Insights
02/22/2024 21:05:13

dynavax-technologies-q4-sales-5560m-beat-5273m-estimate
Dynavax Technologies Q4 Sales $55.60M Beat...
02/22/2024 21:02:35

Dynavax Technologies (NASDAQ:DVAX) reported quarterly sales of $55.60 million which beat the analyst consensus estimate of $52....

earnings-scheduled-for-february-22-2024
Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

goldman-sachs-initiates-coverage-on-dynavax-technologies-with-neutral-rating-announces-price-target-of-20
Goldman Sachs Initiates Coverage On Dynava...
02/01/2024 12:00:51

Goldman Sachs analyst Paul Choi initiates coverage on Dynavax Technologies (NASDAQ:DVAX) with a Neutral rating and announces...

why-rxsight-shares-are-trading-higher-by-20-here-are-other-stocks-moving-in-mondays-mid-day-session
Why RxSight Shares Are Trading Higher By 2...
01/08/2024 18:36:30

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24...

dynavax-sees-prelim-2023-heplisav-b-vaccine-net-product-revenue-213m-up-69-yoy-51m-for-q4-up-46-yoy
Dynavax Sees Prelim. 2023 HEPLISAV-B Vacci...
01/08/2024 14:06:12

jmp-securities-maintains-market-outperform-on-dynavax-technologies-raises-price-target-to-27
JMP Securities Maintains Market Outperform...
11/03/2023 19:43:00

JMP Securities analyst Roy Buchanan maintains Dynavax Technologies (NASDAQ:DVAX) with a Market Outperform and raises the pri...

hc-wainwright--co-maintains-buy-on-dynavax-technologies-raises-price-target-to-28
HC Wainwright & Co. Maintains Buy on Dynav...
11/03/2023 10:58:58

HC Wainwright & Co. analyst Edward White maintains Dynavax Technologies (NASDAQ:DVAX) with a Buy and raises the price ta...

dynavax-technologies-q3-eps-010-sales-6951m-beat-6030m-estimate
Dynavax Technologies Q3 EPS $0.10, Sales $...
11/02/2023 21:33:30

Dynavax Technologies (NASDAQ:DVAX) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of ...

earnings-scheduled-for-november-2-2023
Earnings Scheduled For November 2, 2023
11/02/2023 08:56:34

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on...

earnings-preview-for-dynavax-technologies
Earnings Preview For Dynavax Technologies
11/01/2023 18:01:21

cramer-suggests-buying-fast-food-chain-owner-of-popeyes-burger-king-heres-why
Cramer Suggests Buying Fast Food Chain Own...
09/07/2023 12:34:47

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Restaurant Brands International Inc. (NYSE: QSR) is a buy.

atlassian-universal-display-booking-dropbox-and-other-big-stocks-moving-higher-on-friday
Atlassian, Universal Display, Booking, Dro...
08/04/2023 14:32:23

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)